Publications (11) Celia Martín Otal publications

filter_list

2025

  1. Phosphatidylserine as a tumor target for CAR-T cell therapy

    Journal for ImmunoTherapy of Cancer, Vol. 13, Núm. 2

2024

  1. Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model

    Journal for immunotherapy of cancer, Vol. 12, Núm. 7

2022

  1. Erratum: Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells (J ImmunoTher Cancer (2022) 10 (e004479) DOI: 10.1136/jitc-2021-004479)

    Journal for ImmunoTherapy of Cancer

  2. Impact of tumor microenvironment on adoptive T cell transfer activity

    International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 1-31

  3. Intratumoral electroporation of a self-amplifying RNA expressing IL-12 induces antitumor effects in mouse models of cancer

    Molecular Therapy - Nucleic Acids, Vol. 29, pp. 387-399

  4. Overcoming T cell dysfunction in acidic pH to enhance adoptive T cell transfer immunotherapy

    OncoImmunology, Vol. 11, Núm. 1

  5. TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity

    Cancer Letters, Vol. 528, pp. 45-58

  6. Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells

    Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 8

2021

  1. Intratumoral STING Agonist Injection Combined with Irreversible Electroporation Delays Tumor Growth in a Model of Hepatocarcinoma

    BioMed Research International, Vol. 2021

  2. Searching for peptide inhibitors of t regulatory cell activity by targeting specific domains of foxp3 transcription factor

    Biomedicines, Vol. 9, Núm. 2, pp. 1-20

2020

  1. CD300f immunoreceptor is associated with major depressive disorder and decreased microglial metabolic fitness

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 117, Núm. 12, pp. 6651-6662